Fny Investment Advisers, LLC Mesoblast LTD Transaction History

Fny Investment Advisers, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	BUY	$1.0 - $1.39 $20,000 - $27,799	20,000 New	20,000 $22,000
Q1 2021 Apr 12, 2021	SELL	$8.26 - $11.4 $571,567 - $788,845	-69,197 Closed	0 $0
Q4 2020 Jan 19, 2021	BUY	$8.21 - $18.59 $284,041 - $643,158	34,597 Added 99.99%	69,197 $587,000
Q3 2020 Oct 09, 2020	BUY	$11.33 - $19.81 $392,018 - $685,426	34,600 New	34,600 $642,000
Q1 2019 Apr 17, 2019	SELL	$4.19 - $5.25 $12,570 - $15,750	-3,000 Closed	0 $0
Q4 2018 Jan 22, 2019	BUY	$3.51 - $8.6 $10,530 - $25,800	3,000 New	3,000 $12,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.